Share 'ADD YOUR VOICE: Participate in PPMD’s Gene Therapy Survey'
Patient-Focused Drug Development in action
Companies developing gene therapies, the FDA, and other stakeholders are interested in the treatment priorities of the Duchenne community. Because of this, PPMD has collaborated with RTI International, with financial support from Solid Biosciences and Pfizer, to launch a survey through Duchenne Connect.
The goal of the survey is to learn about your th…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this